The role of paraoxonase in cancer.
Apoptosis
Cancer
Oxidative stress
Paraoxonase
Journal
Seminars in cancer biology
ISSN: 1096-3650
Titre abrégé: Semin Cancer Biol
Pays: England
ID NLM: 9010218
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
20
07
2017
revised:
20
10
2017
accepted:
18
11
2017
pubmed:
25
11
2017
medline:
4
4
2020
entrez:
25
11
2017
Statut:
ppublish
Résumé
The paraoxonase (PON) gene family includes three proteins, PON1, PON2 and PON3. PON1 and PON3 are both associated with high-density lipoprotein (HDL) particles and exert anti-oxidant and anti-inflammatory properties. PON2 and PON3 are intracellular enzymes which modulate mitochondrial superoxide anion production and endoplasmic reticulum (ER) stress-induced apoptosis. The pleiotropic roles exerted by PONs have been mainly investigated in cardiovascular and neurodegenerative diseases. In recent years, overexpression of PON2 and PON3 has been observed in cancer cells and it has been proposed that both enzymes could be involved in tumor survival and stress resistance. Moreover, a lower activity of serum PON1 has been reported in cancer patients. This review summarizes literature data on the role of PONs in human cancers and their potential role as a target for antitumor drugs.
Identifiants
pubmed: 29170064
pii: S1044-579X(17)30191-8
doi: 10.1016/j.semcancer.2017.11.013
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
Aryldialkylphosphatase
EC 3.1.8.1
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
72-86Informations de copyright
Copyright © 2017 Elsevier Ltd. All rights reserved.